Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease

Brain Research Bulletin

Volumn 87, Issue 2-3, 2012, Pages 144-153

  Choi, Dong Young ^a   Lee, Young Jung ^a   Hong, Jin Tae ^a   Lee, Hwa Jeong ^b  

^a Chungbuk National University   (South Korea)

^b Dongshin University   (South Korea)

Author keywords

Alzheimer's; Antioxidant; Polyphenols; Therapeutic

Indexed keywords

4-O METHYLHONOKIOL; ANTHOCYANIN; BLUEBERRY EXTRACT; CAFFEINE; EPICATECHIN; EPICATECHIN 3 GALLATE; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALLIC ACID; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GRAPE SEED EXTRACT; HONOKIOL; KAEMPFEROL; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; OBOVATOL; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; QUERCETIN; RESVERATROL; RUTOSIDE; TERPENOID; THEANINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BLUEBERRY; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INACTIVATION; GINKGO BILOBA; GRAPE; HUMAN; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MEMORY DISORDER; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TARGET CELL; TEA;

ALZHEIMER DISEASE; ANTIOXIDANTS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; POLYPHENOLS; REACTIVE OXYGEN SPECIES;

EID: 84856623196     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.11.014     Document Type: Review

References (135)

1. Andrieu S., Gillette S., Amouyal K., Nourhashemi F., Reynish E., Ousset P.J., Albarede J.L., Vellas B., Grandjean H. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J. Gerontol. A: Biol. Sci. Med. Sci. 2003, 58:372-377.
2. Andrieu S., Ousset P.J., Coley N., Ouzid M., Mathiex-Fortunet H., Vellas B. GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. I. Rationale, design and baseline data. Curr. Alzheimer Res. 2008, 5:406-415.
3. Assuncao M., Santos-Marques M.J., Carvalho F., Lukoyanov N.V., Andrade J.P. Chronic green tea consumption prevents age-related changes in rat hippocampal formation. Neurobiol. Aging 2011, 32:707-717.
4. Augustin S., Huebbe P., Matzner N., Augustin K., Schliebs R., Cermak R., Wolffram S., Rimbach G. Ginkgo biloba extract and its flavonol and terpenelactone fractions do not affect beta-secretase mRNA and enzyme activity levels in cultured neurons and in mice. Planta Med. 2008, 74:6-13.
5. Augustin S., Rimbach G., Augustin K., Schliebs R., Wolffram S., Cermak R. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. Arch. Biochem. Biophys. 2009, 481:177-182.
6. Bastianetto S., Ramassamy C., Dore S., Christen Y., Poirier J., Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur. J. Neurosci. 2000, 12:1882-1890.
7. Bastianetto S., Zheng W.H., Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 2000, 131:711-720.
8. Brewer G.J., Torricelli J.R., Lindsey A.L., Kunz E.Z., Neuman A., Fisher D.R., Joseph J.A. Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract. J. Nutr. Biochem. 2010, 21:991-998.
9. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
10. Bruce-Keller A.J., Gupta S., Parrino T.E., Knight A.G., Ebenezer P.J., Weidner A.M., LeVine H., Keller J.N., Markesbery W.R. NOX activity is increased in mild cognitive impairment. Antioxid. Redox Signal. 2010, 12:1371-1382.
11. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 2002, 36:1307-1313.
12. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 2007, 43:658-677.
13. Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Ma L., Walker L.P., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., Ertekin-Taner N., Crook J.E., Dickson D.W., Petersen R.C., Graff-Radford N.R. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat. Genet. 2009, 41:192-198.
14. Chandrasekaran K., Mehrabian Z., Spinnewyn B., Drieu K., Fiskum G. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res. 2001, 922:282-292.
15. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 2005, 280:40364-40374.
16. Choi I.S., Lee Y.J., Choi D.Y., Lee Y.K., Lee Y.H., Kim K.H., Kim Y.H., Jeon Y.H., Kim E.H., Han S.B., Jung J.K., Yun Y.P., Oh K.W., Hwang D.Y., Hong J.T. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-beta generation and accumulation in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2011, 27:127-141.
17. Choi M.S., Lee S.H., Cho H.S., Kim Y., Yun Y.P., Jung H.Y., Jung J.K., Lee B.C., Pyo H.B., Hong J.T. Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7 cells. Eur. J. Pharmacol. 2007, 556:181-189.
18. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., Park J., Park C.W., Suh S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 2001, 70:603-614.
19. Colciaghi F., Borroni B., Zimmermann M., Bellone C., Longhi A., Padovani A., Cattabeni F., Christen Y., Di Luca M. Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol. Dis. 2004, 16:454-460.
20. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., Dartigues J.F. Intake of flavonoids and risk of dementia. Eur. J. Epidemiol. 2000, 16:357-363.
21. Craft J.M., Watterson D.M., Van Eldik L.J. Neuroinflammation: a potential therapeutic target. Expert Opin. Ther. Targets 2005, 9:887-900.
22. Cui H.S., Huang L.S., Sok D.E., Shin J., Kwon B.M., Youn U.J., Bae K. Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 2007, 14:696-700.
23. Dai Q., Borenstein A.R., Wu Y., Jackson J.C., Larson E.B. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am. J. Med. 2006, 119:751-759.
24. DeFeudis F.V. Effects of Ginkgo biloba extract (EGb 761) on gene expression: possible relevance to neurological disorders and age-associated cognitive impairment. Drug Dev. Res. 2002, 57:214-235.
25. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., Kronmal R.A., Ives D.G., Saxton J.A., Lopez O.L., Burke G., Carlson M.C., Fried L.P., Kuller L.H., Robbins J.A., Tracy R.P., Woolard N.F., Dunn L., Snitz B.E., Nahin R.L., Furberg C.D. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008, 300:2253-2262.
26. Draczynska-Lusiak B., Doung A., Sun A.Y. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol. 1998, 33:139-148.
27. Dragicevic N., Smith A., Lin X., Yuan F., Copes N., Delic V., Tan J., Cao C., Shytle R.D., Bradshaw P.C. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J. Alzheimers Dis. 2011, 26:507-521.
28. Duffy K.B., Spangler E.L., Devan B.D., Guo Z., Bowker J.L., Janas A.M., Hagepanos A., Minor R.K., DeCabo R., Mouton P.R., Shukitt-Hale B., Joseph J.A., Ingram D.K. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiol. Aging 2008, 29:1680-1689.
29. Dumont M., Beal M.F. Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic. Biol. Med. 2011, 51:1014-1026.
30. Eckert A., Keil U., Kressmann S., Schindowski K., Leutner S., Leutz S., Muller W.E. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 2003, 36(Suppl. 1):S15-S23.
31. Ferruzzi M.G., Lobo J.K., Janle E.M., Cooper B., Simon J.E., Wu Q.L., Welch C., Ho L., Weaver C., Pasinetti G.M. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J. Alzheimers Dis. 2009, 18:113-124.
32. Francis F.J. Food colorants: anthocyanins. Crit. Rev. Food Sci. Nutr. 1989, 28:273-314.
33. Fukui H., Diaz F., Garcia S., Moraes C.T. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14163-14168.
34. Goyarzu P., Malin D.H., Lau F.C., Taglialatela G., Moon W.D., Jennings R., Moy E., Moy D., Lippold S., Shukitt-Hale B., Joseph J.A. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr. Neurosci. 2004, 7:75-83.
35. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992, 21:334-350.
36. Grossi C., Francese S., Casini A., Rosi M.C., Luccarini I., Fiorentini A., Gabbiani C., Messori L., Moneti G., Casamenti F. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 2009, 17:423-440.
37. Guedj F., Sebrie C., Rivals I., Ledru A., Paly E., Bizot J.C., Smith D., Rubin E., Gillet B., Arbones M., Delabar J.M. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One 2009, 4:e4606.
38. Guo J.P., Yu S., McGeer P.L. Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy. J. Alzheimers Dis. 2010, 19:1359-1370.
39. Haque A.M., Hashimoto M., Katakura M., Hara Y., Shido O. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J. Nutr. Biochem. 2008, 19:619-626.
40. Ho L., Chen L.H., Wang J., Zhao W., Talcott S.T., Ono K., Teplow D., Humala N., Cheng A., Percival S.S., Ferruzzi M., Janle E., Dickstein D.L., Pasinetti G.M. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J. Alzheimers Dis. 2009, 16:59-72.
41. Hoi C.P., Ho Y.P., Baum L., Chow A.H. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 2010, 24:1538-1542.
42. Hughes T.F., Andel R., Small B.J., Borenstein A.R., Mortimer J.A., Wolk A., Johansson B., Fratiglioni L., Pedersen N.L., Gatz M. Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. Am. J. Geriatr. Psychiatry 2010, 18:413-420.
43. Ito K., Iida T., Ichino K., Tsunezuka M., Hattori M., Namba T. Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem. Pharm. Bull. (Tokyo) 1982, 30:3347-3353.
44. Jang J.H., Surh Y.J. Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 2003, 34:1100-1110.
45. Janle E.M., Lila M.A., Grannan M., Wood L., Higgins A., Yousef G.G., Rogers R.B., Kim H., Jackson G.S., Ho L., Weaver C.M. Pharmacokinetics and tissue distribution of 14C-labeled grape polyphenols in the periphery and the central nervous system following oral administration. J. Med. Food 2010, 13:926-933.
46. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
47. Joseph J.A., Denisova N.A., Arendash G., Gordon M., Diamond D., Shukitt-Hale B., Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr. Neurosci. 2003, 6:153-162.
48. Joseph J.A., Shukitt-Hale B., Brewer G.J., Weikel K.A., Kalt W., Fisher D.R. Differential protection among fractionated blueberry polyphenolic families against DA-, Abeta(42)- and LPS-induced decrements in Ca(2+) buffering in primary hippocampal cells. J. Agric. Food Chem. 2010, 58:8196-8204.
49. Joseph J.A., Shukitt-Hale B., Willis L.M. Grape juice, berries, and walnuts affect brain aging and behavior. J. Nutr. 2009, 139:1813S-1817S.
50. Kalfon L., Youdim M.B., Mandel S.A. Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J. Neurochem. 2007, 100:992-1002.
51. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54:111-118.
52. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
53. Kim J., Lee H.J., Lee K.W. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J. Neurochem. 2010, 112:1415-1430.
54. Kim T.I., Lee Y.K., Park S.G., Choi I.S., Ban J.O., Park H.K., Nam S.Y., Yun Y.W., Han S.B., Oh K.W., Hong J.T. l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic. Biol. Med. 2009, 47:1601-1610.
55. Kowaltowski A.J., de Souza-Pinto N.C., Castilho R.F., Vercesi A.E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 2009, 47:333-343.
56. Kuriyama S., Hozawa A., Ohmori K., Shimazu T., Matsui T., Ebihara S., Awata S., Nagatomi R., Arai H., Tsuji I. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am. J. Clin. Nutr. 2006, 83:355-361.
57. Lannfelt L., Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J., Masters C.L., Targum S., Bush A.I., Murdoch R., Wilson J., Ritchie C.W. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008, 7:779-786.
58. Lau F.C., Bielinski D.F., Joseph J.A. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J. Neurosci. Res. 2007, 85:1010-1017.
59. Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr. 2009, 139:1987-1993.
60. Lee J.W., Lee Y.K., Lee B.J., Nam S.Y., Lee S.I., Kim Y.H., Kim K.H., Oh K.W., Hong J.T. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol. Biochem. Behav. 2010, 95:31-40.
61. Lee M., Kwon B.M., Suk K., McGeer E., McGeer P.L. Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage. J. Neuroimmune Pharmacol. 2011, in press.
62. Lee S.K., Kim H.N., Kang Y.R., Lee C.W., Kim H.M., Han D.C., Shin J., Bae K., Kwon B.M. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg. Med. Chem. 2008, 16:8397-8402.
63. Lee S.Y., Cho J.S., Yuk D.Y., Moon D.C., Jung J.K., Yoo H.S., Lee Y.M., Han S.B., Oh K.W., Hong J.T. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB. J. Pharm. Sci. 2009, 111:124-136.
64. Lee Y.J., Choi I.S., Park M.H., Lee Y.M., Song J.K., Kim Y.H., Kim K.H., Hwang D.Y., Jeong J.H., Yun Y.P., Oh K.W., Jung J.K., Han S.B., Hong J.T. 4-O-methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic. Biol. Med. 2011, 50:66-77.
65. Lee Y.J., Lee Y.M., Lee C.K., Jung J.K., Han S.B., Hong J.T. Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 2011, 130:157-176.
66. Lee Y.K., Song J.K., Choi I.S., Jeong J.H., Moon D.C., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Neurotrophic activity of obovatol on the cultured embryonic rat neuronal cells by increase of neurotrophin release through activation of ERK pathway. Eur. J. Pharmacol. 2010, 649:168-176.
67. Leifert W.R., Abeywardena M.Y. Cardioprotective actions of grape polyphenols. Nutr. Res. 2008, 28:729-737.
68. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78:1073-1082.
69. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem. Pharmacol. 2002, 63:21-29.
70. Li N., Song Y., Zhang W., Wang W., Chen J., Wong A.W., Roberts A. Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract. Regul. Toxicol. Pharmacol. 2007, 49:154-159.
71. Lin C.J., Huang H.C., Jiang Z.F. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains. Brain Res. Bull. 2010, 82:235-242.
72. Lin Y.R., Chen H.H., Ko C.H., Chan M.H. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 2006, 537:64-69.
73. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 2002, 156:445-453.
74. Liu P., Kemper L.J., Wang J., Zahs K.R., Ashe K.H., Pasinetti G.M. Grape seed polyphenolic extract specifically decreases abeta*56 in the brains of tg2576 mice. J. Alzheimers Dis. 2011, 26:657-666.
75. Liu Z., Zhang X., Cui W., Li N., Chen J., Wong A.W., Roberts A. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul. Toxicol. Pharmacol. 2007, 49:160-171.
76. Longpre F., Garneau P., Christen Y., Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1 and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic. Biol. Med. 2006, 41:1781-1794.
77. Lovell M.A., Markesbery W.R. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 2007, 85:3036-3040.
78. Luchsinger J.A., Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol. 2004, 3:579-587.
79. Luo Y., Smith J.V., Paramasivam V., Burdick A., Curry K.J., Buford J.P., Khan I., Netzer W.J., Xu H., Butko P. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12197-12202.
80. Maitra I., Marcocci L., Droy-Lefaix M.T., Packer L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol. 1995, 49:1649-1655.
81. Mandel S.A., Amit T., Weinreb O., Reznichenko L., Youdim M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008, 14:352-365.
82. Marcocci L., Maguire J.J., Droy-Lefaix M.T., Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 1994, 201:748-755.
83. Marcocci L., Packer L., Droy-Lefaix M.T., Sekaki A., Gardes-Albert M. Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 1994, 234:462-475.
84. Markesbery W.R., Lovell M.A. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 2007, 64:954-956.
85. Matsui N., Takahashi K., Takeichi M., Kuroshita T., Noguchi K., Yamazaki K., Tagashira H., Tsutsui K., Okada H., Kido Y., Yasui Y., Fukuishi N., Fukuyama Y., Akagi M. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res. 2009, 1305:108-117.
86. Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Beal M.F. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 2002, 59:794-798.
87. Minghetti L., Greco A., Puopolo M., Combrinck M., Warden D., Smith A.D. Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease. J. Neuroinflammat. 2006, 3:4.
88. Monagas M., Gomez-Cordoves C., Bartolome B., Laureano O., Ricardo da Silva J.M. Monomeric, oligomeric, and polymeric flavan-3-ol composition of wines and grapes from Vitis vinifera L. Cv. Graciano, Tempranillo, and Cabernet Sauvignon. J. Agric. Food Chem. 2003, 51:6475-6481.
89. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006, 67:1370-1376.
90. Moyers S.B., Kumar N.B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 2004, 62:204-211.
91. Mullen W., Marks S.C., Crozier A. Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. J. Agric. Food Chem. 2007, 55:3148-3157.
92. Muller W.E., Eckert A., Kurz C., Eckert G.P., Leuner K. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol. Neurobiol. 2010, 41:159-171.
93. Na H.K., Kim E.H., Jung J.H., Lee H.H., Hyun J.W., Surh Y.J. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch. Biochem. Biophys. 2008, 476:171-177.
94. Na H.K., Surh Y.J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem. Toxicol. 2008, 46:1271-1278.
95. Nathan C., Calingasan N., Nezezon J., Ding A., Lucia M.S., La Perle K., Fuortes M., Lin M., Ehrt S., Kwon N.S., Chen J., Vodovotz Y., Kipiani K., Beal M.F. Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 2005, 202:1163-1169.
96. Nurk E., Refsum H., Drevon C.A., Tell G.S., Nygaard H.A., Engedal K., Smith A.D. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J. Nutr. 2009, 139:120-127.
97. Nurk E., Refsum H., Drevon C.A., Tell G.S., Nygaard H.A., Engedal K., Smith A.D. Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br. J. Nutr. 2010, 104:1190-1201.
98. Ock J., Han H.S., Hong S.H., Lee S.Y., Han Y.M., Kwon B.M., Suk K. Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br. J. Pharmacol. 2010, 159:1646-1662.
99. Oh J.H., Kang L.L., Ban J.O., Kim Y.H., Kim K.H., Han S.B., Hong J.T. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected]. Chem. Biol. Interact. 2009, 180:506-514.
100. Oken B.S., Storzbach D.M., Kaye J.A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch. Neurol. 1998, 55:1409-1415.
101. Ono K., Condron M.M., Ho L., Wang J., Zhao W., Pasinetti G.M., Teplow D.B. Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J. Biol. Chem. 2008, 283:32176-32187.
102. Owuor E.D., Kong A.N. Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmacol. 2002, 64:765-770.
103. Park E.S., Lim Y., Lee S.H., Kwon B.M., Yoo H.S., Hong J.T., Yun Y.P. Antiplatelet activity of obovatol, a biphenolic component of magnolia obovata, in rat arterial thrombosis and rabbit platelet aggregation. J. Atheroscler. Thromb. 2011, 18:659-669.
104. Park L., Zhou P., Pitstick R., Capone C., Anrather J., Norris E.H., Younkin L., Younkin S., Carlson G., McEwen B.S., Iadecola C. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1347-1352.
105. Perrone G., Nicoletti I., Pascale M., Rossi A.D., Girolamo A.D., Visconti A. Positive correlation between high levels of ochratoxin A and resveratrol-related compounds in red wines. J. Agric. Food Chem. 2007, 55:6807-6812.
106. Polidori M.C., Pratico D., Mangialasche F., Mariani E., Aust O., Anlasik T., Mang N., Pientka L., Stahl W., Sies H., Mecocci P., Nelles G. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J. Alzheimers Dis. 2009, 17:921-927.
107. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur. J. Pharmacol. 2006, 545:51-64.
108. Resende R., Moreira P.I., Proenca T., Deshpande A., Busciglio J., Pereira C., Oliveira C.R. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic. Biol. Med. 2008, 44:2051-2057.
109. Rhein V., Giese M., Baysang G., Meier F., Rao S., Schulz K.L., Hamburger M., Eckert A. Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PLoS One 2010, 5:e12359.
110. Rinaldi P., Polidori M.C., Metastasio A., Mariani E., Mattioli P., Cherubini A., Catani M., Cecchetti R., Senin U., Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24:915-919.
111. Rogers E.J., Milhalik S., Orthiz D., Shea T.B. Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J. Nutr. Health Aging 2004, 8:92-97.
112. Romeo L., Intrieri M., D'Agata V., Mangano N.G., Oriani G., Ontario M.L., Scapagnini G. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J. Am. Coll. Nutr. 2009, 28(Suppl.):492S-499S.
113. Sadik K., Wilcock G. The increasing burden of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2003, 17(Suppl. 3):S75-S79.
114. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
115. Sharma H.S., Drieu K., Alm P., Westman J. Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat. Acta Neurochir Suppl 2000, 76:81-86.
116. Sharma M., Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 2002, 71:2489-2498.
117. Shukitt-Hale B., Lau F.C., Carey A.N., Galli R.L., Spangler E.L., Ingram D.K., Joseph J.A. Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutr. Neurosci. 2008, 11:172-182.
118. Singh M., Arseneault M., Sanderson T., Murthy V., Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 2008, 56:4855-4873.
119. Smith P.F., Maclennan K., Darlington C.L. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J. Ethnopharmacol. 1996, 50:131-139.
120. Sonnen J.A., Breitner J.C., Lovell M.A., Markesbery W.R., Quinn J.F., Montine T.J. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic. Biol. Med. 2008, 45:219-230.
121. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp. Neurol. 2003, 184:510-520.
122. Tang B.L. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis. Brain Res. Bull. 2010, 81:359-361.
123. Tendi E.A., Bosetti F., Dasgupta S.F., Stella A.M., Drieu K., Rapoport S.I. Ginkgo biloba extracts EGb 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem. Res. 2002, 27:319-323.
124. Truelsen T., Thudium D., Gronbaek M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59:1313-1319.
125. Wadsworth T.L., Bishop J.A., Pappu A.S., Woltjer R.L., Quinn J.F. Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J. Alzheimers Dis. 2008, 14:225-234.
126. Wang J., Ho L., Zhao W., Ono K., Rosensweig C., Chen L., Humala N., Teplow D.B., Pasinetti G.M. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:6388-6392.
127. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D.L., Thiyagarajan M., Percival S.S., Talcott S.T., Pasinetti G.M. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2006, 20:2313-2320.
128. Wang J., Santa-Maria I., Ho L., Ksiezak-Reding H., Ono K., Teplow D.B., Pasinetti G.M. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010, 22:653-661.
129. Wang Y.J., Thomas P., Zhong J.H., Bi F.F., Kosaraju S., Pollard A., Fenech M., Zhou X.F. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox. Res. 2009, 15:3-14.
130. Wilkinson B.L., Landreth G.E. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J. Neuroinflammat. 2006, 3:30.
131. Williams C.M., El Mohsen M.A., Vauzour D., Rendeiro C., Butler L.T., Ellis J.A., Whiteman M., Spencer J.P. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 2008, 45:295-305.
132. Xing G., Dong M., Li X., Zou Y., Fan L., Wang X., Cai D., Li C., Zhou L., Liu J., Niu Y. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Res. Bull. 2011, 85:212-218.
133. Yao Z., Drieu K., Papadopoulos V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Res. 2001, 889:181-190.
134. Yu J.T., Wang N.D., Ma T., Jiang H., Guan J., Tan L. Roles of beta-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics. Brain Res. Bull. 2011, 84:111-117.
135. Zhang X.Z., Li X.J., Zhang H.Y. Valproic acid as a promising agent to combat Alzheimer's disease. Brain Res. Bull. 2010, 81:3-6.